Clinical trial Recruiting at 1 site Interventional Ages 45 to 74 Women only

AberTea: fermented seaweed English breakfast tea for heart and blood vessel health during menopause

Official title: The Effect of the Fermented Seaweed Enriched Abertay Tea on Vascular Function and Markers of Cardiovascular Risk During Menopause

Run by Abertay University · NCT07070635 · Data updated 2026-11-12

This trial will test whether drinking three cups a day of AberTea (English breakfast tea enriched with fermented brown seaweed) for eight weeks can improve blood pressure and blood vessel function in postmenopausal women.

More Cardiovascular Risk Factor trials

Quick facts

Study typeInterventional
Ages45 Years to 74 Years
SexWomen only
Enrollment44 (estimated)
SponsorAbertay University
Academic / other
Locations1 site (Dundee)
StatusRecruiting
StartedJune 16, 2025
Main results expectedOctober 2025
Study endsNovember 2025
Registry record updatedJuly 17, 2025
Trial IDNCT07070635 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are postmenopausal women who regularly drink tea, have a BMI of 18.5–39.99 kg/m2, and do not have major cardiovascular disease, diabetes, or contraindicating medications.

Probably not a fit

Women with existing cardiovascular disease, diabetes, recent cancer, thyroid impairment, active smokers or vapers, excessive alcohol intake, recent hormone therapy, or on excluded medications are not eligible and unlikely to receive benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Abertay University will run a double-blind, parallel randomized trial comparing AberTea — an English breakfast tea enriched with fermented brown seaweed — to a control English breakfast tea over eight weeks. Postmenopausal women who are regular tea drinkers will be randomly assigned to drink three cups daily and will undergo fasting baseline and endpoint visits for blood pressure, vascular function testing, and blood sampling. Primary outcomes are blood pressure and vascular function, with secondary outcomes including lipoprotein profiles and glycaemic control; participants are asked not to change diet or activity. Recruitment will occur via university emails, posters, social media and local outreach, with screening to confirm eligibility and safety.

Why it matters

Potential benefit: If successful, the tea could modestly lower blood pressure and improve vascular health in postmenopausal women through a simple daily beverage.

How similar studies have gone: Previous interventional studies of brown seaweed or its extracts have shown reductions in blood pressure and improvements in lipids and glycaemic markers in some populations, though effects vary by seaweed type, dose, and duration.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Postmenopausal status: no menstrual period over the last 12 months
* Regular tea drinkers (at least once a week), willingness to consume 3 cups of English breakfast tea per day for 8 weeks
* BMI between 18.5 and 39.99 kg/m2

Exclusion Criteria:

* Reported history of CVD (myocardial infarction, angina, venous thrombosis, stroke, dyslipidemia), diabetes (or fasting glucose ≥ 6.1 mmol/L), kidney, liver or bowel disease.
* Recent history of cancer (\<1y)
* History indicative of a congenital or acquired platelet or haemostatic defect.
* Presence of gastrointestinal disorder or use of drug, which is likely to alter gastrointestinal motility or nutrient absorption.
* Recent use of hypolipidaemic, antiplatelet or antithrombotic medications
* Impairment of thyroid function
* Current smokers or vapers
* Current self-reported weekly alcohol intake exceeding 14 units
* Current or recent use of hormone replacement therapy (\<3 months)
* Recent participation in another clinical trial (\<3 months)
* Allergy or intolerance to crustaceans or iodine

Where it's running

  • Abertay University
    Dundee, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.